Connect your AI

Ingersoll Rand IR Equity Method Income

Equity Method Income at other companies

FlowserveFLS

$2.99M-47.8%

Thermo Fisher ScientificTMO

-$8M+42.9%

Other financials

Income statement

Revenue$1.8B+7.6%

Gross profit$792.4M+3.5%

Operating income$289.7M-4.2%

Net income$192.1M+3.0%

EPS (diluted)$0.49+6.5%

Balance sheet

Cash & equivalents$1.3B-21.0%

Total debt$4.8B+0.2%

Total equity$10.2B-3.0%

Total assets$18.2B-0.9%

Cash flow

Operating cash flow$199.7M-22.1%

CapEx$36.3M+7.7%

Free cash flow$163.4M-26.6%

Valuation

Market cap$32.09B-10.2%

Enterprise value$35.65B-9.1%

P/E54.7×-13.7×

P/S4.1×-0.7×

Profitability

Gross margin43.2%-0.6pp

Operating margin14.5%-3.4pp

Net margin7.5%-3.8pp

FCF margin14.9%-3.9pp

Returns & leverage

Return on equity5.7%-2.4pp

Debt / equity0.5×0.0×

Current ratio2.2×-0.2×

Where this comes from

Reported directly by Ingersoll Rand in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.

The official record: Ingersoll Rand’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ingersoll Rand's equity method income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Ingersoll Rand's equity method income?: Ingersoll Rand (IR) reported equity method income of $0 in Q1 2026.
How has Ingersoll Rand's equity method income changed year-over-year?: Ingersoll Rand's equity method income increased by 100.0% year-over-year, from -$6.2M to $0.
What is the long-term trend for Ingersoll Rand's equity method income?: Over 4 years (2021 to 2025), Ingersoll Rand's equity method income has grown at a 82.7% compound annual growth rate (CAGR), from -$11.4M to -$127.1M.
What does equity method income mean?: The company's proportional share of net income or loss from unconsolidated affiliates and joint ventures accounted for under the equity method.